Evidence map›Paper›PMID 24792327›Full record

ArticleNeurotoxicology2014

Downregulation of Pink1 influences mitochondrial fusion-fission machinery and sensitizes to neurotoxins in dopaminergic cells.

Liliana Rojas-Charry, Mark R Cookson, Andrea Niño, Humberto Arboleda, Gonzalo Arboleda

Open access · greenAbstract read
In one paragraph

Article in Neurotoxicology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. The cell biology of Parkinson's disease.The Journal of cell biology · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Mitochondrial fission and fusion in secondary brain damage after CNS insults.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2016
    Review
  15. Sphingolipids and mitochondrial apoptosis.Journal of bioenergetics and biomembranes · 2016
    Review
  16. Mitochondrial Biology and Neurological Diseases.Current neuropharmacology · 2016
    Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Liliana Rojas-CharryGrupos de Neurociencias y Muerte Celular, Facultad de Medicina e Instituto de Genética, Universidad Nacional de Colombia, Bogotá, Colombia.
Mark R CooksonLaboratory of Neurogenetics, National Institute of Aging, National Institutes of Health, Bethesda, MD, USA.
Andrea NiñoGrupos de Neurociencias y Muerte Celular, Facultad de Medicina e Instituto de Genética, Universidad Nacional de Colombia, Bogotá, Colombia.
Humberto ArboledaGrupos de Neurociencias y Muerte Celular, Facultad de Medicina e Instituto de Genética, Universidad Nacional de Colombia, Bogotá, Colombia.
Gonzalo ArboledaGrupos de Neurociencias y Muerte Celular, Facultad de Medicina e Instituto de Genética, Universidad Nacional de Colombia, Bogotá, Colombia. Electronic address: gharboledab@unal.edu.co.
Universidad Nacional de Colombia · CONational Institutes of Health · US

Funding

Recessive parkinsonism and mitochondrial functionZIAAG000940 · NIA · NATIONAL INSTITUTE ON AGING · PI COOKSON, MARK · 2009 to 2019
$3.0M
Intramural NIH HHS ZIA AG000940
6 · The paper itself

Abstract

It is now well established that mitochondria are organelles that, far from being static, are subject to a constant process of change. This process, which has been called mitochondrial dynamics, includes processes of both fusion and fission. Loss of Pink1 (PTEN-induced putative kinase 1) function is associated with early onset recessive Parkinson's disease and it has been proposed that mitochondrial dynamics might be affected by loss of the mitochondrial kinase. Here, we report the effects of silencing Pink1 on mitochondrial fusion and fission events in dopaminergic neuron cell lines. Cells lacking Pink1 were more sensitive to cell death induced by C2-Ceramide, which inhibits proliferation and induces apoptosis. In the same cell lines, mitochondrial morphology was fragmented and this was enhanced by application of forskolin, which stimulates the cAMP pathway that phosphorylates Drp1 and thereby inactivates it. Cells lacking Pink1 had lower Drp1 and Mfn2 expression. Based on these data, we propose that Pink1 may exert a neuroprotective role in part by limiting mitochondrial fission.

Indexed as

AnimalsApoptosisCell Line, TumorDopaminergic NeuronsDown-RegulationGene Knockdown TechniquesHumansMiceMitochondriaMitochondrial ProteinsProtein KinasesPTEN-Induced Putative KinaseRotenoneSphingosineMitochondrial ProteinsN-acetylsphingosineProtein KinasesPTEN-Induced Putative KinaseRotenoneSphingosineCeramideMitochondrial dynamicsParkinsonPink1Rotenone

Identifiers

PMID24792327
PMCPMC4778252
OpenAlexW2006183701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.